Your browser doesn't support javascript.
loading
ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow, D; Temel, J S; Abernethy, A; Milanowski, J; Friend, J; Fearon, K C.
Afiliación
  • Currow D; ImPACCT - Improving Palliative Aged and Chronic Care through Clinical Research and Translation, Faculty of Health, University of Technology Sydney, Sydney, Australia.
  • Temel JS; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston.
  • Abernethy A; Department of Medicine, Duke University School of Medicine, Durham, USA.
  • Milanowski J; Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.
  • Friend J; Helsinn Therapeutics (U.S.) Inc., Iselin, USA.
  • Fearon KC; Department of Surgery, Royal Infirmary, Edinburgh, UK.
Ann Oncol ; 28(8): 1949-1956, 2017 Aug 01.
Article en En | MEDLINE | ID: mdl-28472437

Texto completo: 1 Colección: 01-internacional Asunto principal: Oligopéptidos / Caquexia / Carcinoma de Pulmón de Células no Pequeñas / Receptores de Ghrelina / Hidrazinas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Asunto principal: Oligopéptidos / Caquexia / Carcinoma de Pulmón de Células no Pequeñas / Receptores de Ghrelina / Hidrazinas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Australia